<DOC>
	<DOCNO>NCT00376376</DOCNO>
	<brief_summary>Single-dose study fluoroquinolone indicative antimicrobial activity since little accumulation occur multiple dos . Single-dose study utilized determine drug concentration time kill activity serum , urine , respiratory tissue . The purpose study evaluate Urine Bactericidal Activity ( UBA ) levofloxacin ( 250 , 500 , 750 , 1000 mg ) FQ-resistant , ESBL positive E. coli isolates . In addition , susceptibility breakpoint concentration urine also establish dose levofloxacin . Furthermore , urine concentration serum pharmacokinetic parameter levofloxacin determine .</brief_summary>
	<brief_title>Urinary Bactericidal Activity 4 Doses Levofloxacin Against Fluoroquinolone-Resistant E. Coli</brief_title>
	<detailed_description>Subjects : -10 healthy ( medical history ) adult male female volunteer - Normal body weight ( within 20 % ) - Age range : 18-60 - Not take restrict medication ( ie . antibiotic ) Drug : drug single dose give 12 hour fast - 1000 mg.levofloxacin - 750 mg. levofloxacin - 500 mg levofloxacin - 250 mg levofloxacin Levofloxacin Pharmacokinetic Study : A serum sample obtain prior 1.5 ( peak ) , 4.0 , 8.0 , 12 ( 50 % interval ) 24 ( 100 % interval ) hour single dose levofloxacin ( 6 time point ) . Levels determine HPLC assay . Urine Pharmacodynamic Study : A urine sample obtain prior 1.5 ( peak ) , 4 , 8 , 12 ( 50 % interval ) , 24 ( 100 % interval ) hour single dose dose levofloxacin . A urine pH run sample . All urine level determine validate HPLC assay . Study Isolates : E. coli ( TRUST isolates ) : Levofloxacin MICs : - 0.125 ( sensitive ) - 4.0 ( intermediate ) - 8.0 ( resistant ) - 16.0 ( resistant ) - 32.0 ( resistant ) - 64.0 ( resistant ) This MIC range E. coli isolates able define levofloxacin susceptibility breakpoint urinary pathogen dose study . Urine Cidal Activity : Urine sample test study isolates . A maximum urine cidal titer determine urine . The median titer time period ( 10 subject ) determine urine cidal activity . The duration cidal activity isolate determine plot . A 12-h duration consider minimum time necessary prolong Urine Bactericidal Activity ( MIC breakpoints ) . Safety : All patient monitor side effect study .</detailed_description>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>healthy ( medical history ) adult male female volunteer Normal body weight ( within 20 % ) Age range : 1860 Not take restrict medication ( ie . antibiotic ) Nonhealthy volunteer pregnant woman volunteer antibiotic body weight 20 % normal Age &lt; 18 &gt; 60</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>levofloxacin</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>bactericidal</keyword>
</DOC>